Pharmaceutical Newsletter - September 19 to 23, 2016

India Infoline News Service | Mumbai | September 23, 201617:29 IST

This week saw Lincoln Pharma develop new NDDS formulation in India, Aurobindo Pharma gets tentative approval of Dolutegravir 50mg from USFDA. IIFL presents a weekly snapshot of all the major happenings in the Pharmaceutical industry.

Top News
 
Lincoln Pharma develops new NDDS formulation in India
Lincoln Pharmaceuticals Limited, engaged in manufacturing of Pharma products like Tablets, Capsules, Injectables, Syrups, Ointments etc. at its state of art, fully automated,  ultramodern,  WHO-GMP standards and IS0-9001 certified manufacturing activities near  Ahmedabad. Lincoln Pharmaceuticals Limited is glad to inform that our R&D department has developed Ondansetron Oral Spray (Domi Up). Domi Up Spray is NDDS (Novel Drug Delivery System) formulation.
 
Presently the Ondansetron formulation is available in the form of Tablet, Syrup and Injectable. Lincoln Pharma has developed Ondansetron (Domi Up) as Oral spray as First Time in India. This formulation is available in U.S. market only. Lincoln Pharma has done the Bio-Equivalent Study for Ondansetron Oral Spray and got the DCGI permission. Lincoln Pharma has launched Ondansetron  (Domi-up) Spray in Indian Market. Read More
 
News Infocus
 
This International Peace Day, Remember to Maintain your Work Life Balance with Yoga Apps
International Day of Peace is observed all over the world on 21 September to strengthen the ideals of peace among people and nations. No matter what your working hours are, or how stressful your job is or isn't, you really should take time out for maintaining your work life balance. These five apps on this International Day will make it easier for you to learn and practice in yoga at your convenience to maintain your work life balanced. These apps are designed to make it easier to understand what the different asanas are for, and how to go about doing yoga which brings inner peace. Read More
 
80% Weight loss dependant on food intake, not exercise, say experts
On the occasion of National Nutrition Week, dieticians from Columbia Asia Hospital caution people about eating right—in terms of quantity and quality. The idea is not to lose weight dramatically, but for it to be a gradual process that is sustainable. The World Health Organization (WHO) defines nutrition as the “intake of food, considered in relation to the body’s dietary needs”, and this is a concept that the hospital is promoting. WHO defines being overweight if the body mass index (BMI) is greater than 25 and less than 30. Over that, an adult is considered obese. Excess body fat can result in a higher BMI. India has now emerged as the third most obese country after USA and China. Childhood obesity is also touching alarming proportions recently, as India reported more than 15 million obese children in 2015. Read More
 
Car dashboard Injuries on rise, say Doctors at Indian Spinal Injuries Centre
Vehicle dashboard injuries are a matter of growing concern and can cause major injuries, alignment issues, as well as trauma, say Doctors at Indian Spinal Injuries Centre, New Delhi. Depending on the type and the severity of the car crash or collision, these injuries can result in serious, far-reaching physical and mental health issues. With vehicle accidents on the rise, doctors are trying their best to educate people so that accidents are reduced and if they do take place, injury is minimized. Read More
 
Domestic Newsmakers
 
Aurobindo Pharma gets tentative approval of Dolutegravir 50mg from USFDA for treatment of HIV
Aurobindo Pharma Limited announce the tentative approval of Dolutegravir 50mg from US Food & Drug Administration (USFDA) for the treatment of HIV. This important milestone marks the first FDA approval of a generic version of Dolutegravir (DTG), an integrase strand transfer inhibitor recommended for use in treatment-naïve patients by the US Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO). Through an innovative collaboration with ViiV and the Clinton Health Access Initiative, Inc. (CHAI), the product is expected to be launched in sub-Saharan Africa in late 2016. Read More
 
K. J. Somaiya Hospital unveils its newly refurbished Ayurveda Centre
K. J. Somaiya Hospital, has unveiled its newly refurbished Ayurveda Centre, which now has an increased capacity for Ayurveda dispensary and Ayurveda Garden on the grounds of the hospital. To provide patients a calming ambience, nature and tradition have been kept in perfect balance in the new design of the Centre; with classic traditional wooden facilities, walls painted with Indian murals, wide large windows providing natural light and a view of greenery, evoking a feeling of well-being. Read More 
 
Credihealth launches Tele Consult facility through their platform
Credihealth, India’s No.1 Medical Assistance Company announced the launch of Tele Consult facility through their platform. With this service, patients will be able to consult marquee doctors of Medanta, one of the leading names among the top 10 world class hospitals, through Video Chat, Phone or Emails.
 
Credihealth is the only platform that empowers patients to teleconsult top-notch specialist doctors from trusted hospitals, from the convenience of their home. A patient can easily avail a 2nd opinion without waiting in long queues or travelling long distances to the hospital. This service would also eliminate the barriers of distance and improve access to health services that may not be available in rural areas, thus helping the remote patients to reduce their frequent travel to hospitals. Credihealth has served over 1, 00,000 patients in last one year and is available across 10 cities - Delhi NCR, Mumbai, Kolkata, Hyderabad, Chennai, Bangalore, Pune, Ranchi, Jaipur and Indore. Read More
 
Indoco Remedies acquires Manufacturing plant at Baddi
Indoco Remedies has acquired the manufacturing facility located at Baddi of Micro Labs Ltd., (a Bangalore based company). The facility is spread over an area of 18,000 sq.mt, out of which 11,000sq.mt.is the built-up area. It produces 4.3 billion tablets and 50 million capsules p.a. The acquired manufacturing site is close to Indoco's existing manufacturing plant in Baddi, Himachal Pradesh. Baddi will thus be another manufacturing hub for Indoco's solid dosages business in the regulated markets. With this acquisition, Indoco will now have 6 facilities for finished dosages and 3 for APIs. Out of these, 3 facilities for finished dosages, including sterile plant and 2 facilities for API manufacturing are USFDA approved.
 
Zydus and Takeda enter into partnership to address emerging infectious diseases
Zydus Cadila, an innovation driven global healthcare provider and Takeda Pharmaceutical Company Limited, today announced a partnership to tackle chikungunya, an emerging infectious d isease. The chikungunya virus is most often spread to people by Aedesaegypti and Aedesalbopictus mosquitoes, the same vectors that spread dengue and zika. The broad­ based agreement includes early stage development to the final commercialisation of the vaccine. There is currently no vaccine to prevent or medicine to treat chikugunya virus infection. Read More
 
Dr. Reddy's Laboratories announces the launch of Paricalcitol Injection in the US Market
Dr. Reddy's Laboratories Ltd announced today that it has launched Paricalcitol Injection, USP, in 2 mcg, 5 mcg, 1O mcg, a therapeutic equivalent generic version of Zemplar (paricalcitol) Injection in the United States market approved by the U.S. Food & Drug Administration (USFDA). The Zemplar brand and generic had U.S. sales of approximately $22.5 million MAT for the most recent twelve months ending in July 2016 according to IMS Health. Dr. Reddy's Paricalcitol Injection is available in 2 mcg, 5 mcg, and 10 mcg, and is the first ANDA product launched in the US market.
 
Glenmark announces strategic development & global licencing pact with Particle Sciences
Glenmark Pharmaceuticals, Inc., USA (Glenmark) today announced that it has entered into a strategic Development, License and Commercialization Agreement with Particle Sciences, Inc. to develop and market a generic version of Celgene’s ABRAXANE product – paclitaxel protein (albumin)-bound particles for injectable suspension. Read More
 
Biocon appoints Suresh Subramanian as Head of Branded Formulations India Business
Biocon Ltd, Asia's premier biopharmaceuticals company, announced today that Suresh Subramanian has been appointed as Head of the Company's Branded Formulations (India) business. Suresh has over 30 years of experience in the pharmaceuticals market, having worked in India and Thailand for MNCs such as GlaxoSmithKline, Novartis, AstraZeneca and Pfizer. Over the years, he has played multiple leadership roles in Business Development, Marketing, Sales and Strategy. He has a rich experience of multiple product launches, business optimization, cost control, talent development and performance  management. Read More
 
International Round Up
 
Innovative Strategies to boost growth in Brazil’s Oral Hygiene Market
Ken Research announced its latest publication on, “Consumer and Market Insights: Oral Hygiene in Brazil” offer insights on the changing trends and key issues within the Brazil’s Oral Hygiene market. The publication includes an insightful analysis of consumer behavior, packaging trends, leading players and distribution trends with in Brazil’s Oral Hygiene market. The analysis of the aforementioned trends has been done across six product categories within the market: Breath Fresheners, Dental Floss, Denture Care, Mouthwashes, Toothbrushes & Replacement Heads and Toothpaste with further individual products under them. Read More
 
Columbia Asia Hospitals launch a comprehensive ‘Diabetes Care Program’
India is the global diabetes capital with the highest number of people being affected by this disease here, as per statistics from the International Diabetes Federation, India Chapter. World Health Organization (WHO) projects that diabetes will be the 7th leading cause of death in 2030. Demanding job hours, erratic lifestyles and increasing prevalence of obesity and physical inactivity are some of the major factors leading to diabetes. An estimated one million Indians die each year due to diabetes. Every adult over the age of 40 is at risk, however, awareness about the disease is still low in the country. Read More
 
Syngene International closes deal with Strand Life Sciences to Purchase Systems Biology and Pharma Services Practice
Syngene International Ltd., Asia’s leading Contract Research Organization, and Strand Life Sciences, announced that they have completed a deal through which Syngene has purchased assets of Strand LifeSciences related to systems biology, Heptox and pharma bioinformatics services. This includes target dossier business and rights to NGS data analytics and Sarchitect platforms, supported by a strong scientific team. Financial details of the deal were notdisclosed. Commenting on this development, Jonathan Hunt, Chief Executive Officer,Syngene International said, “Given the vast volumes of genetic material sequence data that is being generated globally, there is an increasing focus on biological information management and data analytics in drug discovery and development. Read More
 
Angola receives 4 million praziquantel tablets
Merck, a leading science and technology company, announced that the largest delivery of praziquantel tablets ever shipped to Angola recently arrived in Luanda, the capital of country. Angola has received around 4 million tablets for mass distribution to school children. According to the World Health Organization (WHO), Angola is one of the most endemic countries for schistosomiasis worldwide. It is estimated that around 26% of the overall population requires treatment. Angola has been participating in the Merck Praziquantel Donation Program since 2008 and has received nearly 12 million tablets to date. Read More

 

Advertisements

  • Get your free IIFL Demat & Trading A/c now...Click here
  • Get the most detailed result analysis on the web - Real Fast!
  • Actionable & Award-Winning Research on 500 Listed Indian Companies.